BRIGATINIB vs ERDAFITINIB

Do you or your loved one have experience with Brigatinib (Alunbrig) for the first line treatment of ALK Positive NSCLC? Help Lung Cancer Canada provide insight by contacting us to share your experience and help lung cancer patients get access to this treatment. Email us at [email protected].

hey all 💗 it’s been a minute. my 16yo is in the sweet spot: highly concerning tumors have grown, but are not affecting function as of now. we’ve made the decision to start brigatinib in june, at the end of the school year. we have avastin on the back burner, trying to start with least “disruptive

My father, male, age 65, was diagnosed with Stage IV non-small cell lung cancer this past June. He has since undergone whole brain radiation and began taking the medication alectinib as his cancer contains an ALK mutation. After a couple of months, the alectinib caused terrible abdominal pain and hi

hi all ✨ sending everyone some love. also, long story short, my 15yo son has NF2, and has a slowly growing VS in the left; ss deaf from removal of fast-growing binuclear VS on the right. recent growth has sparked discussions of how to preserve his hearing. we have discussed avastin, and are also l

I have shared some details of my mom's experiences on erdafitinib in a clinical trial and wanted to share an amazing update -- she had about a 30% reduction in her tumor today (the image on the left) compared to February (the image on the right). This comes after another 20% reduction she had in ear

TLDR; summary of my BC experience through surgeries, gem/cis, Keytruda/Padcev, radiation, neuropathy that caused me to drop the therapy (cancer was stable), and potential next steps. Today I (43m) had my last dose of Keytruda. Back in April I had my last dose of Padcev. I see people here asking abou

Hi all! A few months back I posted about my mom (68) being put in a clinical trial with erdafitinib after her glioblastoma continued to progress following radiation and chemo after her brain surgery in February of this year. She was a candidate for this trial because of a fairly rare FGFR fusion her

US pharmer here. Hoping for assistance from any pharmacists that work in Canada. Have a patient with pancreatic cancer, oncology has recommended starting of Balversa (erdafitinib). Insurance of course is saying this is a no-go, as it is not currently FDA approved for pancreatic cancer. They are now

Hi all. My mom has recently been enrolled in a clinical trial testing the effectiveness of erdafitinib based off a fairly rare FGFR fusion her tumor has (about 3% of all cases of glioblastoma). She has just started taking the medication within the last week. This is after a 95%+ resection of her tum